New York: Former drug company executive Martin Shkreli was convicted of securities fraud by jurors in a US court in Brooklyn on Friday after a highly publicised month-long trial.

Federal prosecutors had accused the 34-year-old of defrauding investors in his hedge funds and stealing from his old drug company, Retrophin, to pay them back.

On the fifth day of deliberations, jurors found Shkreli guilty on two counts of securities fraud and one count of conspiracy. Shkreli was found not guilty on five other conspiracy counts.

Before going on trial, Shkreli had been best known for raising the price of anti-infection drug Daraprim by 5000 per cent in 2015 as chief executive of Turing Pharmaceuticals.